Andrew Wu

Andrew Wu is an experienced investment professional currently working with Frazier Healthcare Partners on the Growth Buyout Team since July 2023. Previously, Andrew served as a Venture Capital Investor at Rich Products Ventures, focusing on sourcing and investing in innovative companies within the synthetic biology and food tech sectors. Prior to that role, Andrew was a Senior Manager in Business Development and Product Management at Zymergen, engaging in business development and strategy across agriculture, food, and pharmaceuticals. Andrew began a career in investment banking at UBS as an Associate Director, executing debt transactions globally across multiple industries. Academic credentials include an MBA in Finance from The Wharton School and a B.A. in Economics from Yale University.